Point/Counterpoint

Should clopidogrel be discontinued prior to open vascular procedures?


 

References

Michael C. Dalsing, MD, is chief of vascular surgery at Indiana University, Indianapolis. He reported no relevant conflicts.

References

1. J Vasc Surg. 2010;52:825-33

2. Cochrane Database Syst Rev. 2015, Issue 2. Art. No.: CD000535

3. J Vasc Surg. 2016;63:1262-70

4.J Vasc Surg. 2011;54:779-84

5. Vascul Pharmacol. 2016;77:19-27

Pages

Recommended Reading

Endovascular thrombectomy procedure volume for stroke may not affect outcomes
MDedge Surgery
Robotic vascular surgery: Ready for prime time?
MDedge Surgery
Focus on patient-level factors, postop complications to reduce readmissions
MDedge Surgery
Below-knee angioplasty for limb salvage: Keep it simple
MDedge Surgery
Postop delirium linked to greater long-term cognitive decline
MDedge Surgery
Abdominal compartment syndrome – a common adverse event after rAAA repair
MDedge Surgery
NSQIP Study: Symptomatic AAAs have a twofold increased periop mortality risk over asymptomatic
MDedge Surgery
Vascular surgeons assisting nonvascular colleagues require depth/breadth of experience
MDedge Surgery
Commentary: INR instability in the NOAC era
MDedge Surgery
The new NOACs are generally the best bet
MDedge Surgery